4.8 Editorial Material

Are CRISPR Screens Providing the Next Generation of Therapeutic Targets?

Related references

Note: Only part of the references are listed.
Review Biotechnology & Applied Microbiology

Synthetic lethality as an engine for cancer drug target discovery

Alan Huang et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Article Biotechnology & Applied Microbiology

Titrating gene expression using libraries of systematically attenuated CRISPR guide RNAs

Marco Jost et al.

NATURE BIOTECHNOLOGY (2020)

Article Biochemical Research Methods

Targeted Perturb-seq enables genome-scale genetic screens in single cells

Daniel Schraivogel et al.

NATURE METHODS (2020)

Article Oncology

MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors

Thomas P. Howard et al.

CANCER RESEARCH (2019)

Editorial Material Biochemistry & Molecular Biology

ADAR1: A New Target for Immuno-oncology Therapy

Amruta Bhate et al.

MOLECULAR CELL (2019)

Article Multidisciplinary Sciences

WRN helicase is a synthetic lethal target in microsatellite unstable cancers

Edmond M. Chan et al.

NATURE (2019)

Article Multidisciplinary Sciences

Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens

Fiona M. Behan et al.

NATURE (2019)

Article Multidisciplinary Sciences

Next-generation characterization of the Cancer Cell Line Encyclopedia

Mahmoud Ghandi et al.

NATURE (2019)

Article Biochemistry & Molecular Biology

The landscape of cancer cell line metabolism

Haoxin Li et al.

NATURE MEDICINE (2019)

Editorial Material Immunology

Pooled in vivo screens for cancer immunotherapy target discovery

Sarah K. Lane-Reticker et al.

IMMUNOTHERAPY (2018)

Article Immunology

Genome-scale CRI SPR-Cas9 screen identifies druggable dependencies in TP53 wild-type Ewing sarcoma

Bjorn Stolte et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2018)

Article Multidisciplinary Sciences

In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target

Robert T. Manguso et al.

NATURE (2017)

Article Biochemistry & Molecular Biology

Defining a Cancer Dependency Map

Aviad Tsherniak et al.

Article Multidisciplinary Sciences

Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair

Raphael Ceccaldi et al.

NATURE (2015)